Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kempharm (Amphetamine Amino Acid Assets)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Amphetamine amino acid drugs. It develops amphetamine amino acid conjugate products in Coralville, Iowa.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • 2656 Crosspark Road
  • Suite 100
  • Coralville, IA 52241
  • United States

Kempharm (Amphetamine Amino Acid Assets) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Kempharm (Amphetamine Amino Acid Assets)‘s full profile, request access.

Request full access to PitchBook

Kempharm (Amphetamine Amino Acid Assets) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Kempharm (Amphetamine Amino Acid Assets)‘s full profile, request access.

Request full access to PitchBook